Get the Daily Brief
Latest Biotech News
AI and Automation Transform Biotech Research and Clinical Workflows
Integration of AI, robotics, and automation is accelerating discoveries and clinical efficiency. Innovations include AI-powered enzyme engineering with autonomous labs, AI-based early PTSD...
AbbVie Bets Big on In Vivo CAR-T with $2.1 Billion Capstan Acquisition
AbbVie has announced a $2.1 billion acquisition of Capstan Therapeutics, marking a significant expansion into the in vivo CAR-T therapy arena. Capstan’s lead program, CPTX2309, a phase 1 anti-CD19...
Psychedelic Drug Advances Trigger Beckley-Atai Merger Plans
Beckley Psytech and Atai Life Sciences have announced positive Phase 2b results for their intranasal psychedelic drug, mebufotenin, demonstrating significant symptom reduction in...
AI and Machine Learning Transform Biomedical Research and Diagnostics
Artificial intelligence and machine learning continue to make landmark advances in biomedical applications. From university-led projects developing AI-powered leukemia-on-a-chip platforms to...
New Chemotherapy Mutation Signatures Inform Safer Cancer Treatments
Researchers from the Wellcome Sanger Institute, University of Cambridge, and Cambridge University Hospitals have uncovered novel DNA mutational signatures induced by various chemotherapy agents in...
Moderna’s mRNA Flu Vaccine Surpasses Expectations in Late-Stage Trial
Moderna reported compelling phase 3 results for its mRNA-based seasonal influenza vaccine, mRNA-1010, showing 26.6% greater efficacy in preventing influenza-like illness among adults aged 50 and...
Liver Cancer Prognostics Enhanced by New Biomarker and Machine Learning Insights
Innovative studies in hepatocellular carcinoma (HCC) have identified improved methods to predict patient outcomes. Research highlights include the discovery of prognostic power in...
Biotech Financing and Industry Leadership Shakeups Mark Market Activity
Recent weeks have seen significant venture capital movements and leadership changes within the biotech sector. Catalio Capital closed a $400 million Nexus Fund IV, enabling new startup launches...
Biological Insights Into Parkinson’s Disease Emerge from Diverse Studies
A series of groundbreaking investigations are deepening the understanding of Parkinson’s disease pathology and treatment. Research includes the modulation of brain networks through different...
Gut Bacteria Bioaccumulate Toxic PFAS Chemicals Affecting Human Health
Researchers have discovered that human gut bacteria can bioaccumulate per- and polyfluoroalkyl substances (PFAS), widely known as 'forever chemicals' that persist in the human body and environment...
AbbVie Acquires Capstan Therapeutics: $2.1 Billion Bet on In Vivo CAR-T
AbbVie has agreed to acquire Capstan Therapeutics for up to $2.1 billion, aiming to expand its footprint in the emerging in vivo CAR-T therapy market. Capstan’s lipid nanoparticle-based mRNA...
Mid-Stage Success Spurs Beckley Psytech and Atai Merger in Psychedelic Depression Therapy
Beckley Psytech’s intranasal psychedelic treatment for treatment-resistant depression has met key endpoints in a Phase 2b trial, prompting a merger with Atai Life Sciences. The compound,...
Moderna’s mRNA Flu Vaccine Outperforms Competitors, Sets Stage for FDA Submission
Moderna announced strong Phase 3 results for its mRNA-based influenza vaccine, demonstrating a 26.6% relative efficacy over an approved standard-dose seasonal flu shot in adults aged 50 and older...
Chemotherapy-Induced Genetic Mutations Illuminate Safer Treatment Pathways
A collaborative study from the Wellcome Sanger Institute and University of Cambridge has delineated distinct mutational signatures in normal blood cells associated with various chemotherapy...
Novel AI Platforms and Machine Learning Models Enhance Cancer Prognosis and Drug Discovery
Innovations in artificial intelligence are transforming oncology diagnostics and drug discovery. Imagene AI secured $23 million in Series B funding to advance multimodal digital pathology models...
Breakthrough in Glioblastoma Targeting Molecular Motors Improves Treatment Response
Researchers at the Herbert Wertheim UF Scripps Institute unveiled MT-125, a novel drug targeting non-muscle myosin IIA and IIB, that sensitizes glioblastoma tumors to radiation and kinase...
Advances in Parkinson’s Disease Diagnostics and Therapeutics Driven by Machine Learning and Brain Stimulation
A series of studies highlight pivotal shifts in Parkinson’s disease research and treatment. Machine learning models have been developed to track levodopa’s acute effects via digital speech...
Emerging Immunotherapies and Molecular Targets in Cancer Treatment
Recent breakthroughs showcase innovative immunotherapy approaches and target identifications in oncology. ARX788 combined with pyrotinib outperformed standard regimens in HER2+ breast cancer,...
Regulatory and Market Dynamics Impacting Biotech Sector Financing and Operations
The biotech industry faces significant operational challenges as Apple Tree Partners engages in litigation with its main investor, citing funding failures threatening portfolio startups' survival....
AbbVie Buys In Vivo CAR-T Biotech for $2.1 Billion
AbbVie has announced the acquisition of Capstan Therapeutics for up to $2.1 billion in cash, marking a significant expansion into in vivo CAR-T therapies. Capstan’s lead candidate, CPTX2309, a...